Argenex Profit Margin 2017-2021 | ARGX
Current and historical gross margin, operating margin and net profit margin for Argenex (ARGX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Argenex net profit margin as of June 30, 2021 is -63.22%.
|Argenex Annual Profit Margins
|Argenex Quarterly Profit Margins
||Medical - Biomedical and Genetics
argenx SE is a biopharmaceutical company. It focuses on developing antibody-based therapies for the treatment of autoimmune diseases and cancer. The company's product pipeline consists of ARGX-113, ARGX-110 and ARGX-111 which are in clinical trials. argenx SE is based in Breda, the Netherlands.